Furthermore, we identified important differences in functional capacities between IBD and the healthy controls that may contribute to the onset or exacerbation of IBD-related symptoms such as diarrhea, intestinal bleeding, mucin degradation, and intestinal inflammation. This evidence concerns the gene MUC5AC and inflammatory bowel disease.